Trastuzumab-DM1 is highly effective in preclinical models of HER2-positive gastric cancer

Autor: Barok, Mark, Tanner, Minna, Köninki, Katri, Isola, Jorma
Zdroj: In Cancer Letters 2011 306(2):171-179
Databáze: ScienceDirect